期刊文献+

甲氨蝶呤联合米非司酮治疗异位妊娠的效果分析 被引量:23

The effect and its influencing factor of ectopic pregnancy treated with methotrexate combined with mifepristone
下载PDF
导出
摘要 目的 探讨影响甲按蝶呤联合米非司酮治疗异位妊娠效果的相关因素.方法 选择2009年1月~2013年6月在我院住院治疗的异位妊娠患者110例,按治疗方法不同分成:MTX+ RU486组50例和MTX组60例两组,对两组患者的治疗效果及副作用进行比较,并用Logistic回归分析影响联合用药治疗效果的因素.结果 MTX+ RU486组治疗异位妊娠的有效率为94.00%,MTX组为81.67%,差异有统计学意义(P<0.05).在治疗成功患者中,MTX+RU486组血β-HCG降至阴性所需时间少于MTX组,差异有统计学意义(P<0.05).两组患者用药后不良反应的发生率差异无统计学意义(P>0.05).Logistic回归分析影响联合用药组治疗效果的唯一因素是β-HCG水平.结论 甲氨蝶呤联合米非司酮治疗异位妊娠,成功率高,疗程短,安全可靠,值得临床推广应用。 Objective To compare the effect and side-reaction of MTX+ RU486 with MTX in treatment of ectopic pregnancy and study the related factors affecting MTX+ RU486 treatment. Methods 110 patients diagnosed as ectopic pregnancy were recruited in this study. According to the two different treatment methods, they were assigned into MTX + RU486 group (50 patients) and MTX group(60 patients ). The effect and side-reaction of the two groups were compared and Logistic model analysis of multiple factors was used to study the prognostic factors of MTX+ RU486 treatment. Results The effective rates in MTX+ RU486 group and MTX group were 94.00% and 81. 67% respectively, the difference was significant(P〈0.05). The time of β-HCG to negative of MTX+ RU486 group were less than MTX group in successful treatment patients, the difference was significant(P〈0.05). The only factor on the effect of MTX+ RU486 group was the level of the β -HCG in Logistic model analysis of multiple factors. Vice-reaction were not signifi- cantly different. Conclusion The methods using MTX+ RU486 to treat ectopic pregnancy has the advantages of high effective rates, short course of treatment, safe and reliable, worthy of clinical application.
出处 《西部医学》 2015年第5期765-767,770,共4页 Medical Journal of West China
关键词 异位妊娠 药物治疗 氨甲蝶呤 米非司酮 影响因素 Ectopic pregnancy Medical treatment Methotrexate Mifeprisfone Influencing facor
  • 相关文献

参考文献15

  • 1丰有吉.妇产科学[M].第2版.北京:人民卫生出版社,2010:68-69.
  • 2Barnhart KT. Clinical practice. Ectopic pregnancy[J]. N Engl J Med, 2009,361 .. 379-387.
  • 3F Moll E, van den Boogaard, NM van Mello, et al. Guideline adherence in ectopic pregnancy management [J]. Hum Reprod, 2011,26 : 307-315.
  • 4Norah M van Mello, Femke Mol, Willem M Ankum, et al. Ec topic pregnancy: how the diagnostic and therapeutic manage ment has changed ~-J~. Fertility and Sterility, 2012, 98:1066 1073.
  • 5张佳丽,熊正爱.异位妊娠药物治疗研究进展[J].中华妇幼临床医学杂志(电子版),2011,7(1):68-71. 被引量:12
  • 6袁会敏.异位妊娠的药物治疗[J].中外健康文摘,2012,9(24):207-208.
  • 7Tanaka T, Hayashi H, Kutsuzawa T, et al. Treatment of inter- stitial ectopic pregnancy with methotrexate:report of a success- ful case[J]. Fertil Steril,1982,37(6):851-852.
  • 8Hajenius PJ,Mol F, Mol BW,Bossuyt PM, et al. Interventions for tubal ectopie pregnancy[J~. Cochrane Database Syst Rev, 2007, (1) : CD000324.
  • 9Perdu M, Camus E, Rozenberg P,et al. Treating ectopic preg- nancy with the combination of mifepristone and methotrexate : a phase II nonrandomized study[J]. America Journal of Obstetrics and Gynecology, 1998,179 ; 640-643.
  • 10张玲.异位妊娠药物治疗两种方案比较[J].药物流行病学杂志,2006,15(3):142-143. 被引量:4

二级参考文献61

共引文献318

同被引文献128

引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部